| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/27/2002 | EP1181017A1 Metalloprotease inhibitors |
| 02/27/2002 | EP0971907B1 Method for producing 1,3-di-substituted 2-nitroguanidines |
| 02/27/2002 | CN1337961A Heteroaryl amidines, methyl amidiues and guanidines as protease inhibitors |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337888A Sonic impinging jet crystallization apparatus and process |
| 02/27/2002 | CN1337851A Converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| 02/27/2002 | CN1079794C Ether compound, use thereof, and intermediate for producing the compound |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
| 02/26/2002 | US6350879 Enzyme inhibitors |
| 02/26/2002 | US6350878 Intermediates for the synthesis of epothilones and methods for their preparation |
| 02/26/2002 | US6350784 Phytochemicals, surfactant, folic acid, |
| 02/26/2002 | US6350774 Antithrombotic agents |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | US6350760 Substituted piperidines as melanocortin-4 receptor agonists |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/21/2002 | WO2002014323A2 Polymorphs of an epothilone analog |
| 02/21/2002 | WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators |
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors |
| 02/21/2002 | WO2002013864A1 Medicinal compositions for preventing and treating cancer |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | WO2001082873A3 A medicinal aerosol formulation |
| 02/21/2002 | WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 02/21/2002 | WO2001079196A3 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives |
| 02/21/2002 | WO2001079187A3 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 02/21/2002 | WO2001019791A3 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022643 1,1- and 1,2-disubstituted cyclopropane compounds |
| 02/21/2002 | US20020022641 For therapy of metabolic disorders related to insulin resistance or hyperglycemia, typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenic inflammation, glaucoma |
| 02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/21/2002 | US20020022631 Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase |
| 02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
| 02/21/2002 | US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | DE10039265A1 New 2-acylamino-5-aminosulfonyl-1,3-thiazole derivatives, useful as antiviral agents, especially for treatment or prophylaxis of herpes simplex virus infections |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/20/2002 | EP1180519A1 Hydrochloride of fused-heterocycle compound |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | EP1180029A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336927A Cyclic guanidine derivatives and their use as pesticides |
| 02/20/2002 | CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester |
| 02/20/2002 | CN1336366A Intermediate of N-benzyl dioxothiazolidinyl benzoyl amide derivatives, and its prepn. method |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348628 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 02/19/2002 | US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes |
| 02/19/2002 | US6348480 Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases |
| 02/19/2002 | US6348477 Substituted phenyl thiazole derivatives as viricides |
| 02/19/2002 | US6348460 Treatment of plant diseases |
| 02/19/2002 | US6348459 Sultam and sultone derived oxazolidinones |
| 02/19/2002 | US6348032 Method of inhibiting neoplastic cells with benzimidazole derivatives |
| 02/19/2002 | CA2203274C Apolipoprotein-b synthesis inhibitors |
| 02/19/2002 | CA2025939C Carboxamides of isoxazole- and isothiazole-carboxylic acids |
| 02/19/2002 | CA2024040C Dibenz [b,f] [1,4]oxazepin (and thiazepin)-11 (10h)-ones and-thiones and their use in the prevention or treatment of aids |
| 02/14/2002 | WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | WO2002012234A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012233A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012232A1 Tartrate salt of thiazolidinedione derivative |
| 02/14/2002 | WO2002012231A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012187A1 Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors |
| 02/14/2002 | WO2002006230A8 Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | US20020019531 Indoles |
| 02/14/2002 | US20020019527 Antitumor, antcarcinogenic agents |
| 02/14/2002 | US20020019434 Indole derivatives having an antiviral activity |
| 02/14/2002 | US20020019404 Anticancer agents, skin disorders |
| 02/14/2002 | US20020019402 Integrin inhibitors and their methods of use |
| 02/14/2002 | US20020019394 Bicyclic sulfonyl amino inhibitors of factor Xa |
| 02/14/2002 | DE10037618A1 Substituierte Heterocyclylakylamino-1,3,5-triazine Heterocyclylakylamino substituted-1,3,5-triazines |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2418895A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | CA2417829A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | CA2417828A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | CA2417827A1 Tartrate salt of thiazolidinedione derivative |
| 02/14/2002 | CA2417818A1 L(+) tartrate salt of thiazolidinedione derivative |
| 02/14/2002 | CA2417358A1 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | CA2415469A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | CA2415022A1 Cinnoline compounds |
| 02/13/2002 | EP1179343A1 Remedies for diabetes |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178971A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 02/13/2002 | EP1178970A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
| 02/13/2002 | EP1178968A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
| 02/13/2002 | EP1178967A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178965A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178964A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |